206 related articles for article (PubMed ID: 14748060)
1. Direct evidence that naturally occurring mutations within hepatitis B core epitope alter CD4+ T-cell reactivity.
Torre F; Cramp M; Owsianka A; Dornan E; Marsden H; Carman W; Williams R; Naoumov NV
J Med Virol; 2004 Mar; 72(3):370-6. PubMed ID: 14748060
[TBL] [Abstract][Full Text] [Related]
2. Specificity of humoral and cellular immune response against recombinant particles of nucleocapsid protein of human hepatitis B virus in rabbits.
Isaguliants MG; Kadoshnikov YP; Kalinina TI; Smirnov VD; Wahren B
Biochemistry (Mosc); 1998 May; 63(5):551-8. PubMed ID: 9632891
[TBL] [Abstract][Full Text] [Related]
3. Core antigen mutations of human hepatitis B virus in hepatomas accumulate in MHC class II-restricted T cell epitopes.
Hosono S; Tai PC; Wang W; Ambrose M; Hwang DG; Yuan TT; Peng BH; Yang CS; Lee CS; Shih C
Virology; 1995 Sep; 212(1):151-62. PubMed ID: 7545853
[TBL] [Abstract][Full Text] [Related]
4. Characterization of sequence variations in immunodominant regions of the HBV-nucleocapsid protein as a prerequisite for the development of an epitope-based vaccine.
Gruener NH; Gerlach TJ; Ulsenheimer A; Diepolder HM; Wierenga E; Zachoval R; Heeg M; Pape GR; Jung MC
Vaccine; 2007 Jun; 25(26):4960-6. PubMed ID: 17466417
[TBL] [Abstract][Full Text] [Related]
5. Gene heterogeneity of hepatitis B virus isolates from patients with severe hepatitis B.
Wu W; Chen Y; Ruan B; Li LJ
Hepatobiliary Pancreat Dis Int; 2005 Nov; 4(4):530-4. PubMed ID: 16286257
[TBL] [Abstract][Full Text] [Related]
6. HBV core region variability: effect of antiviral treatments on main epitopic regions.
Homs M; Jardi R; Buti M; Schaper M; Tabernero D; Fernandez-Fernandez P; Quer J; Esteban R; Rodriguez-Frias F
Antivir Ther; 2011; 16(1):37-49. PubMed ID: 21311107
[TBL] [Abstract][Full Text] [Related]
7. The high prevalence of the I27 mutant HBcAg18-27 epitope in Chinese HBV-infected patients and its cross-reactivity with the V27 prototype epitope.
Liu HG; Chen WW; Fan ZP; Yang HY; Shi M; Zhang Z; Luan SS; Zhang H; Lu P; Tien P; Wang FS
Clin Immunol; 2007 Dec; 125(3):337-45. PubMed ID: 17900990
[TBL] [Abstract][Full Text] [Related]
8. [Identification of hepatitis B virus genotypes in patients with chronic hepatitis B from different nationalities in ethnic minority areas in Yunnan Province, China].
Bian ZQ; Hua ZL; Yan WY; Liu MQ; Wu DY; Zheng ZX
Zhonghua Yi Xue Za Zhi; 2006 Mar; 86(10):681-6. PubMed ID: 16681927
[TBL] [Abstract][Full Text] [Related]
9. Gradual accumulation of mutations in precore core region of HBV in patients with chronic active hepatitis: implications of clustering changes in a small region of the HBV core region.
Hur GM; Lee YI; Suh DJ; Lee JH; Lee YI
J Med Virol; 1996 Jan; 48(1):38-46. PubMed ID: 8825708
[TBL] [Abstract][Full Text] [Related]
10. Difference in T helper responses during hepatitis flares in hepatitis B e antigen (HBeAg)-positive patients with genotypes B and C: implication for early HBeAg seroconversion.
Yuen MF; Wong DK; Zheng BJ; Chan CC; Yuen JC; Wong BC; Lai CL
J Viral Hepat; 2007 Apr; 14(4):269-75. PubMed ID: 17381719
[TBL] [Abstract][Full Text] [Related]
11. Mapping of immunodominant CD4+ T lymphocyte epitopes of hepatitis C virus antigens and their relevance during the course of chronic infection.
Hoffmann RM; Diepolder HM; Zachoval R; Zwiebel FM; Jung MC; Scholz S; Nitschko H; Riethmüller G; Pape GR
Hepatology; 1995 Mar; 21(3):632-8. PubMed ID: 7875660
[TBL] [Abstract][Full Text] [Related]
12. Core mutations in patients with acute episodes of chronic HBV infection are associated with the emergence of new immune recognition sites and the development of high IgM anti-HBc index values.
Alexopoulou A; Baltayiannis G; Eroglu C; Nastos T; Dourakis SP; Archimandritis AJ; Karayiannis P
J Med Virol; 2009 Jan; 81(1):34-41. PubMed ID: 19031457
[TBL] [Abstract][Full Text] [Related]
13. Hepatitis B virus genotypes and hepatitis B surface antigen mutations in family contacts of hepatitis B virus infected patients with occult hepatitis B virus infection.
Kumar GT; Kazim SN; Kumar M; Hissar S; Chauhan R; Basir SF; Sarin SK
J Gastroenterol Hepatol; 2009 Apr; 24(4):588-98. PubMed ID: 19207682
[TBL] [Abstract][Full Text] [Related]
14. Hepatitis B virus splice-generated protein induces T-cell responses in HLA-transgenic mice and hepatitis B virus-infected patients.
Mancini-Bourgine M; Bayard F; Soussan P; Deng Q; Lone YC; Kremsdorf D; Michel ML
J Virol; 2007 May; 81(10):4963-72. PubMed ID: 17360751
[TBL] [Abstract][Full Text] [Related]
15. Minimal T-cell-stimulatory sequences and spectrum of HLA restriction of immunodominant CD4+ T-cell epitopes within hepatitis C virus NS3 and NS4 proteins.
Gerlach JT; Ulsenheimer A; Grüner NH; Jung MC; Schraut W; Schirren CA; Heeg M; Scholz S; Witter K; Zahn R; Vogler A; Zachoval R; Pape GR; Diepolder HM
J Virol; 2005 Oct; 79(19):12425-33. PubMed ID: 16160170
[TBL] [Abstract][Full Text] [Related]
16. Acute phase HBV-specific T cell responses associated with HBV persistence after HBV/HCV coinfection.
Urbani S; Boni C; Amadei B; Fisicaro P; Cerioni S; Valli MA; Missale G; Ferrari C
Hepatology; 2005 Apr; 41(4):826-31. PubMed ID: 15726541
[TBL] [Abstract][Full Text] [Related]
17. Selection of hepatitis B virus variants with aminoacid substitutions inside the core antigen during interferon-alpha therapy.
Radecke K; Protzer U; Trippler M; Meyer Zum Büschenfelde KH; Gerken G
J Med Virol; 2000 Dec; 62(4):479-86. PubMed ID: 11074477
[TBL] [Abstract][Full Text] [Related]
18. Mimicry between the hepatitis B virus DNA polymerase and the antigenic targets of nuclear and smooth muscle antibodies in chronic hepatitis B virus infection.
Gregorio GV; Choudhuri K; Ma Y; Vegnente A; Mieli-Vergani G; Vergani D
J Immunol; 1999 Feb; 162(3):1802-10. PubMed ID: 9973445
[TBL] [Abstract][Full Text] [Related]
19. Sustained and focused hepatitis B virus nucleocapsid-specific T-cell immunity in liver transplant recipients compared to individuals with chronic and self-limited hepatitis B virus infection.
Bihl F; Loggi E; Chisholm JV; Biselli M; Morelli MC; Cursaro C; Terrault NA; Bernardi M; Bertoletti A; Andreone P; Brander C
Liver Transpl; 2008 Apr; 14(4):478-85. PubMed ID: 18324666
[TBL] [Abstract][Full Text] [Related]
20. Mutation "hot spot" in HLA class I-restricted T cell epitope on hepatitis B surface antigen in chronic carriers and hepatocellular carcinoma.
Chen WN; Oon CJ
Biochem Biophys Res Commun; 1999 Sep; 262(3):757-61. PubMed ID: 10471398
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
